GlassScriptPhysician profile
Judy Ling Chin
NPI 1427013564
$1,469.67
in general payments reported to CMS, 2019-2025
19 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $134 · 2021: $36.00 · 2022: $31.83 · 2023: $65.75 · 2024: $400 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $237.58 | 2019-2020 | |
| Kerecis Limited | $169.86 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Novo Nordisk INC | $124.00 | 2025 | Wegovy |
| Glaxosmithkline, LLC. | $123.59 | 2024 | Ojjaara |
| Elekta, INC. | $117.32 | 2019 | |
| Merck Sharp & Dohme LLC | $116.53 | 2019 | |
| Abbvie INC. | $112.75 | 2024 | |
| Organogenesis INC. | $110.63 | 2023-2025 | Puraply, Puraply Wound Matrix, Affinity |
| Novocure INC. | $91.03 | 2019 | |
| Advanced Accelerator Applications | $67.54 | 2019 | |
| Smith+Nephew, INC. | $37.18 | 2024-2025 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Bayer Healthcare Pharmaceuticals INC. | $33.41 | 2019 | |
| Paratek Pharmaceuticals, INC. | $22.84 | 2023 | Nuzyra |
| Dendreon Pharmaceuticals LLC | $20.50 | 2021 | |
| Bsn Medical INC | $20.19 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $17.39 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Coherus Oncology, INC. | $16.33 | 2022 | |
| Astellas Pharma US INC | $15.50 | 2022 | |
| Photocure INC | $15.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.